Claritin Growth Plateaus As Schering Moves Ahead With Consent Decree
This article was originally published in The Tan Sheet
Executive Summary
Sales of Schering-Plough's Claritin (loratadine) appear to have leveled off following a strong 2003 campaign for the over-the-counter antihistamine
You may also be interested in...
Schering Aims For Long-Term Quality Control With Consent Decree – Hassan
The impact of Schering-Plough's 2002 consent decree has produced the side benefit of transforming the firm into an industry model for good manufacturing practices, according to CEO Fred Hassan
Schering Aims For Long-Term Quality Control With Consent Decree – Hassan
The impact of Schering-Plough's 2002 consent decree has produced the side benefit of transforming the firm into an industry model for good manufacturing practices, according to CEO Fred Hassan
Schering Aims For Long-Term Quality Control With Consent Decree – Hassan
The impact of Schering-Plough's 2002 consent decree has produced the side benefit of transforming the firm into an industry model for good manufacturing practices, according to CEO Fred Hassan